Previous studies showed that miR-1269a acts as a tumor promoter by targeting transforming growth factor β in colorectal cancer (4), tp53 and caspase-9 in lung cancer (6), FOXO1 in hepatocellular carcinoma (5), and RASSF9 in gastric cancer (7). This evidence concerns the gene TP53 and neoplasm.